Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression

  • Authors:
    • Shuji Sasaki
    • Kazuo Yashima
    • Akihiro Hayashi
    • Yohei Takeda
    • Akiko Yasugi
    • Masaharu Koda
    • Koichiro Kawaguchi
    • Kenichi Harada
    • Hisao Ito
    • Yoshikazu Murawaki
  • View Affiliations

  • Published online on: December 30, 2010     https://doi.org/10.3892/ol.2010.231
  • Pages: 217-222
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hypermethylation of the promoter region of the MLH1 gene leads to loss of Mlh1 protein expression and plays a key role in the development of gastric cancer. Little is known about the association between Mlh1 expression and the clinicopathological and patient characteristics in early gastric neoplasia, particularly in endoscopically resected tumors. Immunohistochemistry was used to examine Mlh1 expression in 140 early gastric neoplasias obtained by endoscopic resection and comprising 31 gastric adenomas (GAs) and 109 early gastric cancers (EGCs), and compared them to corresponding clinicopathological and patient data. P53 expression and phenotypic profiles were also analyzed. The rate of reduced Mlh1 expression and P53 overexpression was 9.6 and 6.5% in GAs, and 27.5 and 27.5% in EGCs, respectively. In elderly patients (≥65 years of age), the aberrant expression of Mlh1 in EGCs was more significant in female than in male patients (59.9 vs. 29.8%; P=0.016). In addition, the frequency of aberrant Mlh1 expression in EGCs increased significantly in patients with oncological family histories and elevated gross type (P=0.033 and P=0.04, respectively). Moreover, a significant correlation was observed among aberrant Mlh1, P53-negative and HGM expression. The present findings suggest that loss of Mlh1 expression is associated with age, gender, oncological family history and tumor growth pattern in EGC. Patient and tumor characteristics are key factors in the screening, surveillance and diagnosis of early gastric neoplasia, particularly in elderly individuals.
View Figures
View References

Related Articles

Journal Cover

March-April 2011
Volume 2 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sasaki S, Yashima K, Hayashi A, Takeda Y, Yasugi A, Koda M, Kawaguchi K, Harada K, Ito H, Murawaki Y, Murawaki Y, et al: Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression. Oncol Lett 2: 217-222, 2011.
APA
Sasaki, S., Yashima, K., Hayashi, A., Takeda, Y., Yasugi, A., Koda, M. ... Murawaki, Y. (2011). Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression. Oncology Letters, 2, 217-222. https://doi.org/10.3892/ol.2010.231
MLA
Sasaki, S., Yashima, K., Hayashi, A., Takeda, Y., Yasugi, A., Koda, M., Kawaguchi, K., Harada, K., Ito, H., Murawaki, Y."Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression". Oncology Letters 2.2 (2011): 217-222.
Chicago
Sasaki, S., Yashima, K., Hayashi, A., Takeda, Y., Yasugi, A., Koda, M., Kawaguchi, K., Harada, K., Ito, H., Murawaki, Y."Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression". Oncology Letters 2, no. 2 (2011): 217-222. https://doi.org/10.3892/ol.2010.231